Cost-effective reimbursement analysis for medical technologies in Europe
Procedure coding, payment mechanism, reimbursement tariffs, policy, and HTA considerations in 20 EU countries
White Paper: Market access for medical devices in Europe: England, France, Germany, Italy and Spain
Get insights from MTRC White Papers to advance your understanding of European market access for medical devices
Recent news and posts
Publication Digest: Variations in the Medical Device Authorization and Reimbursement Landscape: A Case Study of 2 Cardiovascular Devices Across 4 Countries
MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest.
In a recent publication, Williams et al. compared the authorization and reimbursement processes for two novel cardiovascular devices (Watchman and Impella) in the US, Canada, the UK, and the Netherlands. Despite earlier approvals in Europe, utilization was limited in all but the US, where uptake of both devices was rapid, facilitated by explicit reimbursement mechanisms. The study illustrates how national policy frameworks influence real-world adoption of medical technologies and provides input for optimizing regulatory and funding strategies.
Access the full-text article here.